Rare Diseases
Conference Coverage
Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?
Key clinical point: A significant proportion of NAFLD-related HCC patients have no cirrhosis at presentation, so clinicians need to maintain a...
News
MicroRNA screening might reveal pancreatic cancer
Major finding: Two panels of microRNAs correctly diagnosed pancreatic cancer in 85% of affected patients and correctly diagnosed chronic...
Conference Coverage
New chemo regimen is active against recalcitrant neuroendocrine tumors
Major finding: The overall response rate was 43% and the clinical benefit rate was 97%. Data source: A randomized phase II trial among 28 patients...
News
Coffee consumption affects cancer risk differently for liver vs. pancreatic cancers
Major finding: Neither total coffee intake (whether decaffeinated or caffeinated, analyzed separately) nor tea intake appears to influence the...
News
Avoid transcutaneous biopsy in adrenocortical carcinoma
Major finding: Transcutaneous biopsy was 51%-84% sensitive for adrenocortical carcinoma, depending on where it was done, and caused complications...
News
Radioisotope therapy slowed metastatic pheochromocytoma, paraganglioma
Major finding: Disease completely resolved in one patient and was stable or improved in a majority of patients 6 months after starting 131I-MIBG...
News
Osteoporosis, osteopenia appear common in Friedreich's ataxia
Major finding: In 20 Friedreich’s ataxia patients, 45% had osteoporosis at the femur and 20% had osteopenia at the same site, while bone mineral...
News
FDA approves denosumab for giant cell tumors
News
Metformin May Reduce Liver Cancer Risk
Major Finding: Metformin use reduced the risk of intrahepatic cholangiocarcinoma by nearly 60%, compared with nonmetformin use.